VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, ...

– Phase 3 azetukalner X-TOLE2 FOS study patient recruitment complete, with topline data anticipated in early 2026 – Phase 3 azetukalner neuropsychiatric studies underway with X-NOVA3 in MDD and X-CEED ...

Four climbers went up and down Everest in under a week with the help of xenon gas—a record-breaking ascent that has ignited controversy in the mountaineering world. To reach the highest point on Earth ...

Our product picks are editor-tested, expert-approved. We may earn a commission through links on our site. Why Trust Us? IF YOU COULD scale Everest and back in less than a week, would you do it? That's ...

It was a travesty—two travesties, actually, separate but inextricably linked. In May 1953, Edmund Hillary and Tenzing Norgay became the first people to reach the summit of Mount Everest, a challenge ...

The use of xenon gas by a group of British mountaineers before they began an expedition to climb the world's highest mountain in less than five days has raised questions about its effectiveness and ...

Last week a quartet of British climbers made it to the top of Mount Everest—and spent less than a week on the total round trip from London. That’s weeks fewer than it usually takes to acclimate to the ...

A group of British men went from London to the summit of Everest and back in less than a week with the help of xenon gas. Mountaineers and the Nepalese government weren’t pleased. Four British ...

KATHMANDU, May 21 (Reuters) - Four British climbers became the first to scale Mount Everest on Wednesday using Xenon gas, which helped them save several weeks that mountaineers need to get used to ...

Lukas Furtenbach of Furtenbach Adventures and his Mission Everest Team just summited Mount Everest in extremely windy conditions, five days after leaving the U.K. and flying to Kathmandu. A ...

We recently published an article titled Massive Sell-Offs Just Hit These 10 Stocks Today. In this article, we are going to take a look at where Xenon Pharmaceuticals Inc. (NASDAQ:XENE) stands against ...

Xenon's lead asset, azetukalner, shows promise in treating focal onset seizures with positive phase IIb results and upcoming phase III data expected by end of 2025. Azetukalner's unique Kv7 potassium ...